These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5757973)

  • 1. [From daily to weekly sulfonamide therapy in ORL].
    Swalué R
    Brux Med; 1968 Oct; 48(10):673-9. PubMed ID: 5757973
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with an oral penicillin-sulfonamide preparation in various otorhinolaryngologic diseases].
    Sinzinger G
    Wien Med Wochenschr; 1969 Dec; 119(50):866-9. PubMed ID: 5385941
    [No Abstract]   [Full Text] [Related]  

  • 3. The sulfonamides.
    Schwartz RH
    Ear Nose Throat J; 1981 May; 60(5):230-2. PubMed ID: 6971749
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical report of a new sulfonamide-pyrazolone association].
    Perfumo G; Fontemaggi O
    Minerva Otorinolaringol; 1965; 15(11):204-11. PubMed ID: 5867202
    [No Abstract]   [Full Text] [Related]  

  • 5. [Penicillin-colimycin association in ORL therapy].
    Lemoyne J; De la Boullaye H
    Ann Otolaryngol Chir Cervicofac; 1965; 82(7):595-9. PubMed ID: 5851840
    [No Abstract]   [Full Text] [Related]  

  • 6. [Modern antibiotic therapy in acute ORL infections. Results of a survey, bacteriological viewpoints and suggestions for antibiotic therapy].
    Pfammatter D; Lüthy R
    Schweiz Med Wochenschr; 1982 Sep; 112(36):1230-8. PubMed ID: 7134949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Short-term therapy of acute respiratory and ORL infections with Clarithromycin].
    Knothe H
    Z Gesamte Inn Med; 1992 Sep; 47(9 Suppl):1-7. PubMed ID: 9022402
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current antibiotic therapy in ORL treatment - principles, possibilities, limitations].
    Naumann P
    Arch Otorhinolaryngol Suppl; 1983; 2():260-73. PubMed ID: 6586139
    [No Abstract]   [Full Text] [Related]  

  • 9. [Propolis in ORL therapeutics. Experience of the ORL department of the Piatra Neamţ District Hospital].
    Andone C; Iorga T; Andronache G; Creţu G; Cărcăleanu D; Stan G
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1984; 29(1):71-7. PubMed ID: 6232665
    [No Abstract]   [Full Text] [Related]  

  • 10. [Viral diseases of ORL region].
    Wilmes AE; Deinhardt F
    Arch Otorhinolaryngol Suppl; 1983; 2():1-9. PubMed ID: 6202286
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic action of Maxilase 3000 in ORL pathology].
    Traissac L; Nègrevergne M
    Rev Laryngol Otol Rhinol (Bord); 1974; 95(9-10):693-6. PubMed ID: 4462172
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use in ORL of a pyrazole anti-inflammatory agent (Tanderyl Geigy). Apropos of 1,253 clinical cases].
    Mounier-Kuhn PP; Fontvieille J; Bouchayer M
    J Fr Otorhinolaryngol Chir Maxillofac; 1965 Nov; 14(7):791-3. PubMed ID: 5854853
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of Ribatran in current ORL practice. (Apropos of 200 cases)].
    Gaillard de Collogny L
    Ann Otolaryngol Chir Cervicofac; 1973; 90(10):671-4. PubMed ID: 4770710
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trial of sodium morrhuate in the treatment of ORL angiomas].
    Costinescu V; Dinu C; Mârţu D
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1981; 26(1):61-2. PubMed ID: 6454221
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of polychemotherapy (bleomycin-cisplatin type) in epidermoid carcinomas of the ORL field in stages T3 or T4; 1st intention or palliative chemotherapy].
    Rebattu JP; Michalet JF; Guyon JM; Colin B
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1983 Apr; 32(4):251-5. PubMed ID: 6190984
    [No Abstract]   [Full Text] [Related]  

  • 16. [Activity of doxycycline in ORL infections].
    Rev Laryngol Otol Rhinol (Bord); 1984; 105(2):137-42. PubMed ID: 6377423
    [No Abstract]   [Full Text] [Related]  

  • 17. [Carbocysteine in catarrhal ORL diseases].
    Bébéar JP; Calas V; Lablache Combier B
    Rev Laryngol Otol Rhinol (Bord); 1990; 111(5):499-501. PubMed ID: 2087616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of a delayed action form of codeine as an antitussive agent in ORL].
    Pennetti F
    Praxis; 1966 Nov; 55(45):1305-8. PubMed ID: 6012671
    [No Abstract]   [Full Text] [Related]  

  • 19. [Trial of tiapride as an analgesic in ORL. Apropos of 5 cases].
    Leroy G
    Rev Laryngol Otol Rhinol (Bord); 1982; 103(1):75-6. PubMed ID: 7111932
    [No Abstract]   [Full Text] [Related]  

  • 20. [Severe algia of the ORL sphere and hydroxocobalamin in massive doses].
    Garcin M
    Ann Otolaryngol Chir Cervicofac; 1971; 88(10):597-604. PubMed ID: 5135219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.